3M Company (Minnesota Mining and Manufacturing Company) - 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for the period ended September 30, 2001. 3M operates globally in six business segments: Industrial, Transportation/Graphics/Safety, Health Care, Consumer/Office, Electro/Communications, and Specialty Materials. The quarter was impacted by weak global economic growth, a strong U.S. dollar, and the terrorist attacks of September 11, 2001, which slowed growth in several businesses post-event.
Key Financial Metrics
| Metric | Q3 2001 | Q3 2000 | 9M 2001 | 9M 2000 |
|---|---|---|---|---|
| Net Sales | $3,967M | $4,270M | $12,216M | $12,588M |
| Operating Income | $620M | $819M | $1,691M | $2,411M |
| Net Income | $394M | $499M | $1,049M | $1,456M |
| Diluted EPS | $0.99 | $1.25 | $2.62 | $3.64 |
| Operating Margin | 15.6% | 19.2% | 13.8% | 19.2% |
| Cash from Operations (9M) | $2,260M (vs $1,768M prior year) | |||
| Total Debt | $3,013M ($1,588M Short-term + $1,425M Long-term) | |||
| Working Capital | $1,550M |
Material Changes vs. Prior Period
- Revenue Decline: Q3 sales fell 7.1% year-over-year due to a 4.8% volume decrease and a 2.7% negative currency impact. The strong U.S. dollar significantly reduced international sales.
- Profitability Pressure: Operating income dropped 24% in Q3 and 30% for the nine-month period. Margins were compressed by lower volumes, higher raw material/energy costs, and currency headwinds.
- Restructuring Charges: The company recorded significant non-recurring charges related to a restructuring plan. Q3 included a $69M charge (accelerated depreciation and severance). Total charges for the first nine months were $466M.
- Segment Performance:
- Health Care: Strongest performer with ~10% volume growth, driven by pharmaceuticals and dental products.
- Electro & Communications: Volume declined 17.5% in Q3 due to slowing electronics and semiconductor markets.
- Specialty Materials: Volume declined 17% in Q3, heavily impacted by the phase-out of perfluorooctanyl chemistry.
Guidance, Outlook, and Risks
- Restructuring Outlook: 3M expects total pre-tax restructuring charges to reach approximately $600M. The plan involves terminating ~5,000 employees by June 2002. The company anticipates annualized savings of $300M, with $75M impacting the second half of 2001.
- Q4 2001 Guidance: Management expects Q4 earnings in the range of $0.95 to $1.05 per share (excluding non-recurring items). This assumes volume declines of 3% to 7% and exchange rates remaining at September 30 levels.
- Legal Contingencies:
- Breast Implants: 3M is a defendant in 373 lawsuits. The company has recorded receivables of $461M for insurance recoveries but notes uncertainty regarding collection timing and amounts.
- Asbestos/Respirator: A recent jury verdict in Mississippi awarded plaintiffs $25M each; 3M's share is estimated at $22.5M. The company plans to appeal and believes the verdict will be overturned. Accrued liabilities for these claims are $122M.
- Accounting Changes: Adoption of SFAS No. 142 (Goodwill) in 2002 will eliminate goodwill amortization, estimated to add 10-12 cents per diluted share to 2001 earnings.
Investor Verification Checklist
- Restructuring Execution: Verify the timeline for the 5,000 job cuts and the realization of the projected $300M in annualized savings.
- Currency Hedging: Monitor the effectiveness of the new hedging program targeting 50% coverage of foreign currency risk by Q1 2002.
- Legal Reserves: Track developments in the Mississippi asbestos verdict appeal and the status of insurance recoveries for breast implant litigation.
- Volume Trends: Assess whether the 3-7% volume decline forecast for Q4 holds, particularly in the Electro and Specialty Materials segments.
- Goodwill Impact: Confirm the financial impact of the SFAS 142 adoption on future earnings reports starting in 2002.